On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Monday, March 30, 2026
Regulatory Biostatistics: A Comprehensive Analysis of the FDA Guidance on Bayesian Methodology in Drug and Biological Product Development
›
The release of the January 2026 FDA Draft Guidance for Industry, titled " Use of Bayesian Methodology in Clinical Trials of Drug and Bi...
›
Home
View web version